日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer

5-氟尿嘧啶、多西他赛和奈达铂（UDON）联合疗法治疗复发或转移性食管癌的II期临床试验

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2018-0653
Ueda, Hiroto; Kawakami, Hisato; Nonagase, Yoshikane; Takegawa, Naoki; Okuno, Tatsuya; Takahama, Takayuki; Takeda, Masayuki; Chiba, Yasutaka; Tamura, Takao; Nakagawa, Kazuhiko
食管癌
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

An association study of the single-nucleotide polymorphism c190C>T (Arg64Cys) in the human testis-specific histone variant, H3t, of Japanese patients with Sertoli cell-only syndrome

一项关于人类睾丸特异性组蛋白变体H3t中单核苷酸多态性c190C>T（Arg64Cys）与日本仅有支持细胞综合征患者的关联性研究

期刊:Asian Journal of Andrology
影响因子:2.7
doi:10.4103/aja.aja_66_17
Miyamoto, Toshinobu; Iijima, Masashi; Shin, Takeshi; Minase, Gaku; Ueda, Hiroto; Saijo, Yasuaki; Okada, Hiroshi; Sengoku, Kazuo
细胞生物学
发表日期：2018
文献求助 收藏

Human male infertility and its genetic causes

男性不育症及其遗传原因

期刊:Reproductive Medicine and Biology
影响因子:3.3
doi:10.1002/rmb2.12017
Miyamoto, Toshinobu; Minase, Gaku; Shin, Takeshi; Ueda, Hiroto; Okada, Hiroshi; Sengoku, Kazuo
Human
发表日期：2017
文献求助 收藏

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer

转移性食管癌姑息性放化疗的临床评价

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.17925
Ueda, Hiroto; Takeda, Masayuki; Ueda, Shinya; Kawakami, Hisato; Okuno, Tatsuya; Takegawa, Naoki; Hayashi, Hidetoshi; Tsurutani, Junji; Tamura, Takao; Ishikawa, Kazuki; Nishimura, Yasumasa; Nakagawa, Kazuhiko
食管癌
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer

西妥昔单抗耐药性结直肠癌患者循环肿瘤DNA中HER2基因组扩增

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.6498
Takegawa, Naoki; Yonesaka, Kimio; Sakai, Kazuko; Ueda, Hiroto; Watanabe, Satomi; Nonagase, Yoshikane; Okuno, Tatsuya; Takeda, Masayuki; Maenishi, Osamu; Tsurutani, Junji; Satoh, Taroh; Okamoto, Isamu; Nishio, Kazuto; Tamura, Takao; Nakagawa, Kazuhiko
肿瘤
肠癌
肿瘤免疫
HER2
发表日期：2016
文献求助 收藏

Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1

表达赫格林（Heregulin）的HER2阳性乳腺癌和胃癌对HER2抑制剂拉帕替尼、曲妥珠单抗和T-DM1表现出异质性敏感性。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.12743
Nonagase, Yoshikane; Yonesaka, Kimio; Kawakami, Hisato; Watanabe, Satomi; Haratani, Koji; Takahama, Takayuki; Takegawa, Naoki; Ueda, Hiroto; Tanizaki, Junko; Hayashi, Hidetoshi; Yoshida, Takeshi; Takeda, Masayuki; Chiba, Yasutaka; Tamura, Takao; Nakagawa, Kazuhiko; Tsurutani, Junji
胃癌
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer.

血浆双调蛋白和赫格林联合分析可预测转移性结直肠癌对西妥昔单抗的反应

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0143132
Yonesaka Kimio, Takegawa Naoki, Satoh Taroh, Ueda Hiroto, Yoshida Takeshi, Takeda Masayuki, Shimizu Toshio, Chiba Yasutaka, Okamoto Isamu, Nishio Kazuto, Tamura Takao, Nakagawa Kazuhiko
肿瘤
肠癌
肿瘤免疫
发表日期：2015
文献求助 收藏